TORRENT DO BRASIL LTDA Gliclazide Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Gliclazide from India and how much does TORRENT DO BRASIL LTDA import?

India exports Gliclazide to 643 buyers globally worth $26.2M. TORRENT DO BRASIL LTDA imports $6.9M (2.2% market share) with 284 shipments from BRAZIL.

Q: What is the average order value for TORRENT DO BRASIL LTDA's Gliclazide imports?

TORRENT DO BRASIL LTDA's average Gliclazide order value is $24.4K per consignment, based on 284 shipments totaling $6.9M.

Q: Who supplies Gliclazide to TORRENT DO BRASIL LTDA?

TORRENT DO BRASIL LTDA sources Gliclazide from 1 verified supplier: TORRENT PHARMACEUTICALS LIMITED ($6.9M, 100.0%). Based on 284 customs records.

Q: How does TORRENT DO BRASIL LTDA compare to other Gliclazide importers?

TORRENT DO BRASIL LTDA ranks #3 among 643 Gliclazide importers from India with 2.2% market share and 284 shipments.

Q: Who are the top Gliclazide importers from India?

Top Gliclazide importers: TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M), RANBAXY FARMACEUTICA LTDA : ($2.3M), FIEGE HEALTHCARE LOGISTICS GMBH ($2.2M).

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

TORRENT DO BRASIL LTDA — Gliclazide Importer #3 | $6.9M Trade Value | TransData Nexus | TransData Nexus

TORRENT DO BRASIL LTDA — Gliclazide Importer Profile

Pharmaceutical Importer · #3 buyer for Gliclazide · $6.9M import value · 284 shipments · BRAZIL · DGFT Verified

TORRENT DO BRASIL LTDA is the #3 importer of Gliclazide from India with $6.9M in import value and 284 verified shipments. TORRENT DO BRASIL LTDA holds a 2.2% market share in Gliclazide imports based in BRAZIL. The company sources from 1 verified supplier across 84 formulations shipped to 1 country. Overall, TORRENT DO BRASIL LTDA imports 6 pharmaceutical products worth $29.0M across 4 therapeutic categories.

TORRENT DO BRASIL LTDA — Gliclazide Import Profile: Suppliers, Formulations & Sources

TORRENT DO BRASIL LTDA — Gliclazide import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Gliclazide to TORRENT DO BRASIL LTDA?

Verified from 284 customs shipment records

Supplier	Value	Shipments	% Share
TORRENT PHARMACEUTICALS LIMITED	$6.9M	284	100.0%

TORRENT DO BRASIL LTDA sources Gliclazide from 1 verified Indian supplier based on 284 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.

How Does TORRENT DO BRASIL LTDA Compare to Nearest Gliclazide Importers?

Buyers ranked immediately above and below #3 by import value

#	Buyer

Where Does TORRENT DO BRASIL LTDA Import Gliclazide To?

Destination countries from 284 verified shipments

Country	Value	Shipments	Share
BRAZIL	$6.9M	284	100.0%

TORRENT DO BRASIL LTDA imports Gliclazide to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $6.9M.

What Gliclazide Formulations Does TORRENT DO BRASIL LTDA Import?

Formulation	Value	Shipments
AZUKON MR TABLET ( GLICLAZIDE MODIFIED R	$1.0M	29
AZUKON MR TABLET (GLICLAZIDE MODIFIED RE	$305.3K	10
AZUKON MR TABLET GLICLAZIDE 30MG MODIFIED RELEASE TABLETS NOS SIZE 10X10 TABLETS	$300.0K	6
AZUKON MR TABLET ( GLICLAZIDE MODIFIED RELEASE 30MG ) NOS SIZE 3X10 TABLETS	$260.3K	6
GLICLAZIDE MR 30MG TABLETS ( GLICLAZIDE	$241.6K	12
AZUKON MR TABLET GLICLAZIDE MODIFIED R	$240.8K	7
GLICLAZIDE MR 30MG TABLETS GLICLAZIDEMODIFIED RELEASE 30 MG NOS SIZE 3 X 10TABLETS	$212.4K	11
GLICLAZIDE MR 30mg TABLETS ( GLICLAZIDE	$189.5K	9
GLICLAZIDE MR 30MG TABLETS (GLICLAZIDE M	$165.7K	11
AZUKON MR TABLET ( GLICLAZIDE MODIFIED RELEASE TABLETS 30 MG ) NOS SIZE 6X10 TABLETS	$160.5K	8

TORRENT DO BRASIL LTDA imports 84 distinct Gliclazide formulations from India. The top formulation is AZUKON MR TABLET ( GLICLAZIDE MODIFIED R with 29 shipments worth $1.0M.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: TORRENT DO BRASIL LTDA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as TORRENT DO BRASIL LTDA's capped import value divided by total capped export value for Gliclazide across all Indian exporters.
5.Verified Records: This page is backed by 284 individual customs records matching TORRENT DO BRASIL LTDA importing Gliclazide, covering 84 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 643+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gliclazide

Gliclazide

TORRENT DO BRASIL LTDA — Gliclazide Importer Profile

TORRENT DO BRASIL LTDA — Gliclazide Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Gliclazide to TORRENT DO BRASIL LTDA?

How Does TORRENT DO BRASIL LTDA Compare to Nearest Gliclazide Importers?

Where Does TORRENT DO BRASIL LTDA Import Gliclazide To?

What Gliclazide Formulations Does TORRENT DO BRASIL LTDA Import?

Regulatory Requirements: Importing Gliclazide into Brazil

Regulatory Authority

Approval Process for Generic Gliclazide

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Gliclazide — Export Intelligence Video

Who Are the Top Buyers of Gliclazide from India and How Much Does TORRENT DO BRASIL LTDA Import?

What Is the Average Order Value for TORRENT DO BRASIL LTDA's Gliclazide Imports?

Who Supplies Gliclazide to TORRENT DO BRASIL LTDA?

How Does TORRENT DO BRASIL LTDA Compare to Other Gliclazide Importers?

About TORRENT DO BRASIL LTDA

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gliclazide Import Data for TORRENT DO BRASIL LTDA

TORRENT DO BRASIL LTDA × Gliclazide

Company Overview

Top Products by TORRENT DO BRASIL LTDA

Related Analysis

Need Detailed Import Data?

Data Source

3	TORRENT DO BRASIL LTDA ★	BRAZIL	$6.5M	226	$29.0K
7	MEDREICH PLC	UNITED KINGDOM	$3.1M	68	$45.7K
8	M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$2.4M	48	$50.0K